STAIRWAY: Faricimab for Wet AMD

Philip Ferrone

Show Description +

Philip J. Ferrone, MD, reviews the structure and outcomes of the STAIRWAY study, a phase 2 trial that assessed the efficacy of faricimab in patients with wet AMD.

Posted: 7/11/2019

Up Next

Name: STAIRWAY: Faricimab for Wet AMD
Uploaded: 2019-07-11T11:30:00+00:00
Description: Philip J. Ferrone, MD, reviews the structure and outcomes of the STAIRWAY study, a phase 2 trial that assessed the efficacy of faricimab in patients with wet AMD.

HARBOR Post-Hoc Analysis: Vision Outcomes and the Presence of Fluid

Nancy Holekamp, MD

Preview to ASRS with Dr. Packo

Kirk Packo, MD

Preview to ASRS 2019 With Dr. Pollack

John Pollack, MD

Higher-Level Analysis of OCT Features

Justis Ehlers, MD

The Winning Pitch: The Shark Tank of Retina

David Williams

Rethinking Risk in Fovea-Sparing RRDs

James Major Jr., MD

What Happens When DR Treatment Is Less Aggressive?

Roger A. Goldberg, MD, MBA

Hyperreflective Foci and Pathologic Risk

Bozho Todorich, MD, PhD

Novel Combination Technique for Closing Challenging Macular Holes

Robert Sisk

A Novel Retinal Tamponade

Tommy Stryjewski, Tony Stefater

1-Year Primary Outcome Data From RECOVERY

Charles Wykoff, MD, PhD

Ranibizumab PDS: How LADDER Informed ARCHWAY

Arshad Khanani, MD

Intravitreal Injections and Clinical Resources

Christina Weng, MD

CST Fluctuations in HAWK and HARRIER

Chirag Jhaveri, MD

Back to All Videos

STAIRWAY: Faricimab for Wet AMD

Philip Ferrone

Philip J. Ferrone, MD, reviews the structure and outcomes of the STAIRWAY study, a phase 2 trial that assessed the efficacy of faricimab in patients with wet AMD.

Posted: 7/11/2019

Please log in to leave a comment.

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

STAIRWAY: Faricimab for Wet AMD

Up Next

STAIRWAY: Faricimab for Wet AMD

More From ASRS: 2019 Coverage